These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15163265

  • 1. Diabetic ketoacidosis, neuroleptic malignant syndrome, and myocardial infarction in a patient taking risperidone and lithium carbonate.
    Ananth J, Johnson KM, Levander EM, Harry JL.
    J Clin Psychiatry; 2004 May; 65(5):724. PubMed ID: 15163265
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
    Mithat B, Alpaslan T, Bulent C, Cengiz T.
    Pharmacopsychiatry; 2005 Mar; 38(2):105-6. PubMed ID: 15744639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T, Westendorp RG.
    Ned Tijdschr Geneeskd; 2005 Mar 12; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract] [Full Text] [Related]

  • 7. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome with risperidone.
    Gleason PP, Conigliaro RL.
    Pharmacotherapy; 1997 Jan 15; 17(3):617-21. PubMed ID: 9165568
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel antipsychotics and neuroleptic malignant syndrome.
    Buckley P.
    Psychiatr Serv; 1996 Apr 15; 47(4):431. PubMed ID: 8689381
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG, Akdede B, Akvardar Y, Akan M, Tunca Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risperidone and NMS?
    Murray S, Haller E.
    Psychiatr Serv; 1995 Sep 30; 46(9):951. PubMed ID: 7583513
    [No Abstract] [Full Text] [Related]

  • 19. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Sep 30; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.